This Week in Virology1 Apr 2023

TWiV 996: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses how antibiotics don't reduce risk of death from viral respiratory infections, norovirus infections continue to rise in the US, ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample, maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization, association of treatment with Nirmatrelvir and the risk of Post–COVID-19 condition, mechanically ventilated patients with COVID-19 had a higher chance of in-hospital death if treated with high-flow nasal cannula oxygen before intubation, high-flow nasal cannula and outcomes in COVID-19, severe infection and risk of Cardiovascular disease, and the risk factors associated with post−COVID-19 condition.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Antibiotics don't reduce risk of death from viral respiratory infections (CIDRAP)
ABO blood types and SARS-CoV-2 infection (Nature)
Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization (Nature Medicine)
Association of treatment with Nirmatrelvir and risk of post–COVID-19 (JAMA)
Ventilated patients with COVID-19 had a higher chance of in-hospital death with usage of nasal cannula oxygen (IARS)
High-flow nasal cannula and outcomes in COVID-19 (IARS)
Severe infection and risk of cardiovascular disease (AHA)
Risk factors associated with post−COVID-19 condition (JAMA)
Contribute to our ASTMH fundraiser at PWB
Dr. Griffin's treatment guide (pdf)
Letters read on TWiV 996
Don't crush Paxlovid (pdf)
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1373)

TWiV 1337: The whitefly and the Red Queen

TWiV explains research that reveals an an alternative evolutionary path of antiviral signalling in a sea anemone, and how a bacterial symbiont and a plant virus enhance insect fitness by inducing phys...

5 Jul 1h 52min

TWiV 1336: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello lament about the new ACIP charter, how administration of the HPV vaccine has eliminated cervical cancer deaths in young women, the ...

4 Jul 23min

TWiV Special: Albert Sabin with Karen Torghele

Vincent speaks with Karen Torghele about her recently published biography of polio vaccine pioneer Albert Sabin, the first ever written. Host: Vincent Racaniello Guest: Karen Torghele Subscribe (free)...

29 Jun 1h 10min

TWiV 1335: TldR, bacterial hot rods and nullifying norovirus

TWiV explains research showing how temperate phages enhance bacterial host fitness via RNA-guided flagellar remodelling, and that IgA antibody is necessary and sufficient to prevent norovirus infectio...

28 Jun 1h 55min

TWiV 1334: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello discuss the global economic burden of infectious disease, restoring trust in vaccinology, the Legionnaires outbreak in Harlem, new ...

27 Jun 31min

TWiV 1334: Clinical update with Dr. Daniel Griffin

27 Jun 31min

TWiV 1333: STING like a nanoparticle, float like HIV

TWiV explains research showing how HIV-1 signalling remodels nuclear pores to licence infection, and development of STING agonist nanoparticles to enable coordinated mucosal-systemic immunity for dura...

21 Jun 1h 54min

TWiV Special: Ebola virus and Andes virus with John Dye

Vincent travels to ASM Microbe in Washington DC to speak with John Dye of the United States Army Medical Research Institute of Infectious Diseases about the recent outbreaks of Bundibugyo ebolavirus i...

20 Jun 57min